This Series on “Convalescent Plasma” is edited by Dr. Massimo Franchini from Carlo Poma Hospital (Italy) and Dr. Cesare Perotti from Fondazione IRCCS Policlinico San Matteo (Italy).
Massimo Franchini, MD
Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy
Dr. Franchini was granted his degree in Medicine in 1991 and the specialization in hematology at the University of Verona (Italy) in 1995. He then became clinical assistant at the Transfusion Center of the University of Verona (Italy) from 1997 to 2008. He was Director of Immunohematology and Transfusion Center of University of Parma (Italy) from 2008 to 2011. He currently serves as Director of the Department of Hematology and Transfusion Medicine of Mantova (Italy) and Director of the Hemostasis and Thrombosis Center of Mantova (Italy).
Dr. Franchini was Associate Editor of Blood Transfusion from 2009 to 2019. He is also Associate Editor of Seminars in Thrombosis and Hemostasis, Member of the Committee of the Italian Association of Hemophilia Centers (AICE) for the revision of the Italian Guidelines on the management of Hemophilia, Member of the Regional Hematology Network (REL, Lombardy Region), subcommittee of Hemostasis and Consultant of the Italian Ministry of Health – National Blood Center.
His main areas of research include hemostasis and thrombosis, immunohematology and transfusion medicine, selection of plasma donors and collection and biological validation of convalescent plasma.
Cesare Perotti, MD
Immunohaematology and Transfusion Service, Apheresis and Cell Therapy Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Dr. Perotti was granted his degree in Medicine in 1980 and the specialization in General Hematology at the University of Pavia (Italy) in 1984. He became assistant in Immunohematology and Transfusion Medicine at IRCCS Policlinico S. Matteo in 1985 and then became Vice-Director in 1994. From 1994 to 2000, Dr. Perotti attended 7 stages in Paris (Hospital ST. Louis), London (Hammersmith Hospital), Los Angeles (City of Hope, Beckman Institute) and Munich (Klinikum Grosshadern) as visiting physician taking care in particular of extracorporeal photochemotherapy, new techniques in stem cell and lymphocytes collection and manipulation, cord blood banking. He currently serves as Director of the Immunohematology and Transfusion Service of Policlinico S. Matteo Foundation.
Dr. Perotti has participated in major national and international conferences in the hematology and immunohematology field since 1990. He attends regularly the ASH and EBMT annual meetings from 1991. He has been Chief of experimental research on transimmunization in cancer since 2004 and Member of the regional commission for stem cells since 2006. He was invited speaker in the annual Ghislieri meeting about the stem cells from 2012 to 2015. He currently serves as Principal Investigator of the protocol - Hyperimmune Plasma for Critical Patients with COVID-19 and Principal Investigator for Policlinico San Matteo Pavia in the SUPPORT¬-E (SUPPORTing high quality evaluation of COVID-19 convalescent Plasma throughout Europe) project.
Dr. Perotti has been responsible of 9 programs of research in the field of cell therapy, stem cell transplantation and regenerative medicine since 1990. He is author of more than 300 scientific papers on international journals and his H index is 36.
- Convalescent plasma for COVID-19
- Convalescent plasma therapy for managing infectious diseases
- Convalescent plasma: rationale for use and mechanisms of action
- The donation of convalescent plasma in Europe
- The donation of convalescent plasma in USA
- COVID-19 and pregnancy: focus on the use of convalescent plasma
- Treatment with convalescent plasma for COVID-19: literature results
- Future therapeutic options for COVID-19
The series “Convalescent Plasma” was commissioned by the editorial office, Annals of Blood without any sponsorship or funding. Massimo Franchini and Cesare Perotti are serving as the unpaid Guest Editors for the series.